Outset Medical (OM) EBIT Margin (2019 - 2026)
Outset Medical's (OM) quarterly EBIT Margin came in at 60.72% in Q1 2026, down 560.0% year-on-year from 13.2% in Q1 2025, and up 0.55% on a QoQ basis from 61.05% in Q4 2025.
Outset Medical (OM) EBIT Margin (2019 - 2026) Analysis & Trends
Outset Medical (OM) has 8 years of EBIT Margin data on file, last reported at 60.72% in Q1 2026.
- On a quarterly basis, EBIT Margin fell 560.0% year-over-year to 60.72% in Q1 2026; TTM through Mar 2026 was 57.17%, a 2339.0% increase from a year earlier, with the FY2025 full-year figure at 55.83%, up 4389.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 60.72%, up from 61.05% in the prior quarter.
- Over the last five years, EBIT Margin for OM reached as high as 53.68% in Q2 2025 and fell as low as 174.49% in Q2 2022.
- Historically, EBIT Margin has averaged 104.34% across 5 years, with a median of 119.39% in 2022.
- Across the five-year window, EBIT Margin tumbled 5589 bps in 2022 and soared 7592 bps in 2025, its largest moves.
- Year by year, EBIT Margin stood at 124.42% in 2022, then grew by 2 bps to 122.44% in 2023, then soared by 39 bps to 74.18% in 2024, then climbed by 18 bps to 61.05% in 2025, then increased by 1 bps to 60.72% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 60.72% in Q1 2026, 61.05% in Q4 2025, and 53.73% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 21.42% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 10.04% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.17% |
| 10 | Outset Medical | 80,106.28 | -286.56 Mn | 12.10 Mn | -60.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.72% |
| Dec 31, 2025 | -61.05% |
| Sep 30, 2025 | -53.73% |
| Jun 30, 2025 | -53.68% |
| Mar 31, 2025 | -55.12% |
| Dec 31, 2024 | -74.18% |
| Sep 30, 2024 | -83.16% |
| Jun 30, 2024 | -112.33% |
| Mar 31, 2024 | -131.04% |
| Dec 31, 2023 | -122.44% |
| Sep 30, 2023 | -149.71% |
| Jun 30, 2023 | -120.64% |
| Mar 31, 2023 | -129.93% |
| Dec 31, 2022 | -124.42% |
| Sep 30, 2022 | -147.69% |
| Jun 30, 2022 | -174.49% |
| Mar 31, 2022 | -119.39% |
| Dec 31, 2021 | -144.92% |
| Sep 30, 2021 | -114.51% |
| Jun 30, 2021 | -118.60% |